Limited drug harm reduction

28 items 1 source

The 10-Year Drugs Strategy's insufficient range of harm reduction approaches, with an over-emphasis on abstinence-based recovery.

Cross-Source Insight

Limited drug harm reduction has been flagged across 1 independent accountability source:

28 PFD reports

This theme has been identified in one data source. As more data is added, cross-references may emerge.

Matthew Singh Prevention of future deaths report
05 Nov 2025 · North Wales (East and Central)
Concerns: High availability and use of illicit psychoactive substances persist at HMP Berwyn, posing significant risks to prisoner health and contributing to future deaths.
Response: HMPPS has implemented physical security enhancements, including anti-drone measures and window improvements, and invested over £40 million this financial year. They have also established Incentivised Substance Free Living Units in …
Overdue
Frederick Ireland-Rose
06 Jun 2025 · Inner North London
Concerns: Cannabinoid vape users are unaware of the significant and variable risk of nitazene adulteration in vaping fluids and lack access to Naloxone, posing a high overdose risk.
Responded
Joshua Leatham-Prosser
27 Feb 2025 · Dorset
Concerns: Ketamine is easily accessible, perceived as less harmful by teenagers, and its highly addictive nature causes severe, irreversible bladder damage (ketamine cystitis), trapping users in a cycle of dependence.
Responded
Joseph Forbes Black
02 Jan 2025 · Inner North London
Concerns: Naloxone kits are not widely available to drug users, especially those not engaged with substance misuse services, despite the increased risk from potent synthetic opioids.
Responded
James Boland
05 Nov 2024 · Manchester South
Concerns: Ketamine's Class B classification falsely portrays it as safer than Class A drugs, encouraging illicit use despite causing severe, life-changing health problems like urological and liver damage.
Responded
Sean Crawford
15 Feb 2024 · County Durham and Darlington
Concerns: There is a critical lack of specific medical and official guidance regarding the fatal risks associated with combining clozapine with alcohol.
Responded
Kristopher Tilbury
08 Sep 2023 · Hertfordshire
Concerns: HMP The Mount failed to control illicit drug supply, including psychoactive substances, leading to high availability even on a 'Wellbeing Wing' and multiple subsequent drug-related deaths.
Overdue
Victoria Storey
30 Jun 2023 · Surrey
Concerns: A highly potent, illicitly traded synthetic opiate with high fatal overdose risk is not yet controlled as a Class A, Schedule 1 drug, despite official advice for its urgent inclusion.
Overdue
Kayleigh Burns
27 Mar 2023 · Warwickshire
Concerns: The legal framework concerning Nitrous Oxide needs review due to increasing use by young persons and its association with deaths.
Overdue
Edward Capovila
25 Apr 2022 · County of Cumbria
Concerns: Insufficient information regarding unusual methods of fentanyl misuse poses a significant risk of future deaths due to its potential for varied abuse.
Responded
James Lacey
29 Nov 2021 · Lancashire & Blackburn with Darwen
Concerns: Harmful substances are easily purchased with less rigorous control than 'regulated poisons,' lacking restrictions like licensing and record-keeping, posing a risk of misuse.
Overdue
Amy Ganner
24 Jun 2021 · Manchester West
Concerns: Insufficient patient education materials regarding opioid tolerance loss and associated toxicity risks are a concern, particularly after periods of abstinence.
Responded
Daniel Mervis
03 Feb 2021 · Inner West London
Concerns: Oxford University lacks an overarching drug misuse policy, and St John's College's conflicting approach of severe penalties versus support may discourage students with addiction from seeking help.
Responded
Kimberley Smith
09 Dec 2020 · Surrey
Concerns: The Trust lacks clear written policies for managing informal patients' leave requests, including risk assessments and monitoring. A vital recommendation for a comprehensive alcohol detoxification protocol also remains unimplemented.
Responded
Matthew Fitten
07 Dec 2019 · Suffolk
Concerns: A change in methadone prescription to larger bottles, without providing a measuring jug, likely led to inaccurate dosing and a fatal overdose.
Responded
George Rimmer
16 Aug 2019 · West Sussex
Concerns: Inadequate patient counselling and insufficient warnings on medication packaging failed to address the dangers of exceeding doses, self-medicating, and unmeasured consumption.
Responded
Matthew Hamilton
14 Feb 2019 · County Durham and Darlington
Concerns: Individuals released from custody are unaware that reduced drug tolerance post-abstinence risks fatal overdose if pre-custody consumption levels are resumed.
Responded
Ian Wolstenholme
08 Aug 2018 · Manchester (North)
Concerns: A lack of national guidance for clinicians on co-prescribing multiple highly addictive and potentially harmful drugs creates a risk of serious harm or death from combined drug toxicity.
Overdue
Anna Phillips
08 Feb 2017 · Cornwall and Isles of Scilly
Concerns: The deceased obtained a dangerous, unlicensed weight loss drug (2,4 Dinitrophenol) online, which is known to cause fatalities.
Responded
Robert Lloyd
29 Nov 2016 · Cornwall and Isles of Scilly
Concerns: Geographical isolation and reduced transport options severely limited face-to-face alcohol support services, leading to reliance on less effective video links and decreased engagement for island residents.
Overdue
Christine Stevenson
10 Mar 2016 · Manchester (South)
Concerns: Large volumes of Oramorph solution, despite containing less than 0.2% morphine, are prescribed without sufficient control. This poses a serious and potentially fatal risk to naive users due to the high total dosage.
Responded
Elvis Snelson
21 Jan 2016 · Manchester City
Concerns: The "legal high" acetylfentanyl, a highly potent opioid, poses significant risks due to users being unaware of its opioid nature, leading to dangerous sedation and respiratory depression.
Overdue
Arenijus Nedzelskies
13 Jan 2016 · South Lincolnshire
Concerns: Specific synthetic cannabinoid receptor agonists (5F AKB-48, 5F PB-22) are not controlled substances, and the deceased's chronic misuse was not reported to the DVLA.
Overdue
Catherine Findlay
13 Oct 2015 · Manchester (West)
Concerns: Concerns about the availability and misuse of dangerous "research chemicals" like MXP, which are freely marketed online, consumed, and pose a life-threatening risk.
Overdue
Kathryn Sawyer
16 Apr 2014 · Norfolk
Concerns: A failure to adequately review and plan a reduction of high-dose addiction medications occurred, alongside a lack of detailed record-keeping regarding medication discussions and future plans.
Responded
Deanne Smith
31 Mar 2014 · London (South)
Concerns: The practice of dispensing large quantities of methadone to drug-dependent individuals over public holidays increases the risk of future deaths and needs policy review.
Overdue
Damion Stanley Joseph Henson
11 Dec 2013 · Cumbria (South & East)
Concerns: A homeless unit, housing drug users, lacked 24-hour supervision, allowing unauthorized individuals to enter out of hours, thereby increasing risks in a facility not designed for drug rehabilitation.
Pending
Christopher Scott
27 Nov 2013 · Wiltshire & Swindon
Concerns: The 'legal high' AMT is readily available for purchase despite clear evidence of its deadly effects, raising concerns about its unregulated status and accessibility to the public.
Pending